Home / Categories / Miscellaneous / Samples / Throwback Thursday
Click to view full size image
Click here for details on how to download this file to your desktop.

Seroquel XL - not enough

When an antidepressant is not enough, add Seroquel XL.

Seroquel XL is now licensed as add-on treatment for patients with major depressive disorder (MDD) who have had suboptimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XL.


Brand name: Seroquel XL
Generic name/category: quetiapine prolonged release
Company: AstraZeneca
Country/Market: UK, Europe
Indication(s)/Category: Major Depression Disorder (MDD)
Target: Healthcare Professionals (HCP)
Tagline: none
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: The British Journal Of Clinical Pharmacy - December 2010

To see more of this brand's ads, click here
Rate this file (No vote yet)
File information
Download:Available for users with full-size access enabled.
Filename:Seroquel_XL-TheBritishJournalOfClinicalPharmacy-December2010.jpg
Keywords:Seroquel brand , 2010 publication year , Seroquel XL , Seroquel , quetiapine prolonged release , Mental illness , Psychiatry , Psychology , Branded , AstraZeneca , UK , Europe , HCP , Prescription , double-page spread , print ad , English , Major Depression Disorder , MDD , Lots Balancing Copy , healthcare category , hcpUK , Blue color , Blue+color , Blue+color , pink color , illustration , clean layout , Pessimistic message , Published , camera , bedroom , depressed , bag , despair , bed , pillow , sheets , sitting , floor , hand , hands , toilet paper
Filesize:3963 KiB
Date added:Dec 11, 2010
Dimensions:2813 x 2000 pixels
URL:https://adpharm.net/displayimage.php?pid=22940
My Collection:Add to collection
About Subscriptions Contact us Twitter LinkedIn